Last reviewed · How we verify
High PSA levels
At a glance
| Generic name | High PSA levels |
|---|---|
| Sponsor | Assuta Medical Center |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (PHASE3)
- Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging (NA)
- The Active Surveillance Study
- The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
- Detection of Minimal Residual Disease Post-prostatectomy
- Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer (EARLY_PHASE1)
- The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
- The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High PSA levels CI brief — competitive landscape report
- High PSA levels updates RSS · CI watch RSS
- Assuta Medical Center portfolio CI